We develop and manufacture advanced intermediates and active pharmaceutical ingredients for both innovative and generic medicines under strictest EU GMP standards.
We offer wide range of contract services such as route-scouting for drug candidates and development of new chemical process. Our QC testing lab has both EU-GMP and ISO-9001 certifications and audited by both authorities and customers.
ADC and PAYLOADS
We have synthesized auristatins, anthracyclines and other ADC payloads for 10 years. We also offer conjugation of payloads to linkers as a routine service, and payload-linker to an antibody using chemical conjugation methods.
Dr. Andrus Tasa
Dr. Olga Tšubrik
Dr. Ain Uustare
Get in touch
Thank You for choosing us!
News & Events
TBD-Biodiscovery is grateful for the opportunity to participate as an exhibitor to CPHI 2019 event in Frankfurt. We value all our collaboration partners and we are specially thankful for the time and effort they put into the meetings! We also greet all new partners and we are hopeful for new projects to begin soon!
November 5-7, 2019 Dr. Olga Tšubrik (Head of Business Development), Dr. Andrus Tasa (Member of the Management Board), Ms. Triin Käbin (Purchase Manager) and Ms. Kristiine Pai (Sales representative) will attend the CPhI Worldwide in Frankfurt. Please visit us in booth 101B88/82 To schedule the meeting please contact us at email@example.com.
TBD-Biodiscovery, a biotechnology company based in Tartu, Estonia’s second largest town, has received an all timelargest investment brought to the Estonian biotech sector. TBD-Biodiscovery’s main activities are production and development of active pharmaceutical ingredients. The company’s premises are in Tartu Biotechnology Park. The new Dutch stakeholder, SEAL Investments B.V acquired 30% of TBD and invests[…]
Hollandi ettevõte investeerib Tartus tegutsevasse ravimiettevõttesse TBD-Biodiscovery 4,5 miljonit eurot, mis on kõigi aegade suurim välisinvesteering Eesti biotehnoloogiaettevõttesse. Tartu Biotehnoloogia Pargis tegutseva ravimite toimeaineid arendava ja müüva ettevõttega TBD-Biodiscovery liitusid Hollandi partnerid firmast SEAL Investment B.V, kes omandasid Eesti ettevõttes 30 protsendilise osaluse ning investeerivad ettevõttesse paari lähima aasta jooksul 4,5 miljonit eurot. TBD-Biodiscovery juhatuse[…]
Chemspec Europe exclusively focuses on the fine, custom and speciality chemicals sector. The international event brings together suppliers and purchasers looking for bespoke products or specific substances to enhance a product/drug or develop new chemical solutions. Dr. Olga Tšubrik (Head of Business Development) will attend Chemspec 26.06-27.06.2019 in Basel.
TBD-Biodiscovery has continuously been supporting local young chemists. Baltic Chemistry Olympiad will be held in Tartu (11.04-13.04.2019). TBD-Biodiscovery will hand over the prize to the best participant in the finals of the experimental work.
March 21, 2019 TBD-Biodiscovery has always supported the education of young chemists. We were happy to introduce our company to young chemistry students and professor Säde Viirlaid from University of Tartu.
March 2019 TBD-team has grown and gained new members. Ms Kristiine Pai joined TBD`sales department as a sales representative and Ms Tiina Tasa as an administrative manager.
March 25-28, 2019 Dr. Olga Tšubrik (Head of Business Development), attended the Bio-Spring 2019 in Vienna.
TBD-Biodiscovery in cooperation with Tartu Biotechnology Park and Association of the Latvian Chemical-Pharmaceutical Industry (LAKIFA) and PharmIdea had a collaboration and matchmaking event. The current situation and collaboration opportunities in the sector in both countries were discussed.